Previous 10 | Next 10 |
Shares of Entasis Therapeutics (ETTX +14.6%) are up sharply after the journal Nature published an article on the potential of its preclinical candidate ETX0462, which could become the first of a new class of antibiotics. ETX0462 is under development for multidrug-resistant Gram-negative and b...
SHANGHAI and SAN FRANCISCO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, announced today that it will expand its operations in the U.S. and establish a key presence in the Cambridge biotech...
SHANGHAI and SAN FRANCISCO, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) granted Break...
The COVID-19 pandemic has accelerated the pace of the global healthcare market’s growth. With the widespread adoption of digital technologies and increased healthcare spending, the industry is expected to witness significant growth. Therefore, Wall Street analysts expect healthcare sto...
SHANGHAI and SAN FRANCISCO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced it will host a Virtual R&D Day for analysts and investors on September 22, 2021. The webcast will take pla...
BAMCO’s 13F portfolio value increased from $40.57B to $43.68B this quarter. Ron Baron increased RingCentral and Cohen & Steers while decreasing Wix.com and Trex. Their top five positions are at ~23% of the overall portfolio. For further details see: Tracking R...
Zhongchao Inc. Expands Patient Management Business to Ovarian Cancer Market PR Newswire SHANGHAI , Aug. 25, 2021 /PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the...
SHANGHAI and SAN FRANCISCO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab”) (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced that management from Zai Lab will be presenting at the following upcoming virtual inv...
The rapidly evolving regulatory landscape in China has persistently populated financial market headlines this summer. The cost of raising a larger family can be daunting, particularly as it relates to the “three mountains” of costs associated with childcare – educ...
Zai Lab Limited (ZLAB) Q2 2021 Earnings Conference Call August 10, 2021 08:00 ET Company Participants Billy Cho - Chief Financial Officer Samantha Du - Founder, Chairperson and Chief Executive Officer Tao Fu - Chief Strategy Officer Alan Sandler - President and Head, Global Development, Oncol...
News, Short Squeeze, Breakout and More Instantly...
First and only NMPA-approved subcutaneous (SC) injectable providing additional flexibility and optionality for gMG patients in China Consistent clinical benefit and safety profile of efgartigimod SC compared to IV demonstrated in Phase 3 ADAPT-SC study Zai Lab Limited (NASDAQ: Z...
Manuscript represents the first publication from China’s gynecology oncology field to be published in Cell Publication highlights first-time learnings about the landscape of ovarian cancer microenvironment stratified by HRD and how a PARP inhibitor perturbs it Data suggest ...
2024-07-05 18:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...